Home / Industry / Healthcare IT / Serum Lactate Testing Market

Serum Lactate Testing Market

Serum Lactate Testing Market Ingredients Market Insights, Competitive Landscape, and Market Forecast 2033

Published Date: Jun 2026 | Format: | No. of Pages: 199

Industry: Healthcare IT | Author Name: Harshad Badbade

Request Customisation / Information

  
$4,995.00
Buy now
Report Description Research Methodology

FAQ : Serum Lactate Testing Market

The global serum lactate testing market is valued at US$210 Million in 2026 and is projected to reach US$ 303.46 Million by 2033.

Mandatory sepsis protocol compliance requirements and government-led diagnostic infrastructure expansion in emerging markets are the primary growth drivers.

North America dominates with 37% share in 2026, driven by high ICU density, strong reimbursement via CPT code 83605, and large-scale hospital procurement systems.

Key opportunities include continuous wearable lactate biosensors and AI-integrated clinical decision support systems enabling real-time lactate monitoring and predictive critical care analytics.

Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, Radiometer, Nova Biomedical, and EKF Diagnostics lead the market.
Fairfield Quality assured
Fairfield Confidentiality assured
Fairfield Custom research services